Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Scanlon

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Health Estate|August 19, 2015
A strategic approach in Scotland outlinedPeter Haggarty, Peter Scanlon
Midwives|June 5, 2014
It's all in the eyePeter Scanlon, Joanne Harcombe
BMJ Case Reports|June 15, 2012
Vitamin B12 deficiency optic neuropathy detected by asymptomatic screeningColin Chu, Peter Scanlon
The Lancet. Diabetes & Endocrinology|March 2, 2020
Screening for diabetic retinopathy: new perspectives and challengesStela Vujosevic, Stephen J Aldington, Paolo Silva, et al.
Diabetes Care|November 26, 2015
Response to Comment on Leese et al. Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals. Diabetes Care 2015;38:488-494Graham P Leese, Irene M Stratton, Martin Land, et al.
Diabetes Care|December 20, 2014
Progression of diabetes retinal status within community screening programs and potential implications for screening intervalsGraham P Leese, Irene M Stratton, Martin Land, et al.
Eye (London, England)|July 10, 2021
Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomesSobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, et al.
Eye (London, England)|March 21, 2023
Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomesSobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, et al.
Eye (London, England)|January 18, 2023
Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomesSobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, et al.
Acta Diabetologica|March 24, 2023
Serum glial fibrillary acidic protein and neurofilament light chain as biomarkers of retinal neurodysfunction in early diabetic retinopathy: results of the EUROCONDOR studyCristina Hernández, Olga Simó-Servat, Massimo Porta, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Health Estate|August 19, 2015
A strategic approach in Scotland outlinedPeter Haggarty, Peter Scanlon
Midwives|June 5, 2014
It's all in the eyePeter Scanlon, Joanne Harcombe
BMJ Case Reports|June 15, 2012
Vitamin B12 deficiency optic neuropathy detected by asymptomatic screeningColin Chu, Peter Scanlon
The Lancet. Diabetes & Endocrinology|March 2, 2020
Screening for diabetic retinopathy: new perspectives and challengesStela Vujosevic, Stephen J Aldington, Paolo Silva, et al.
Diabetes Care|November 26, 2015
Response to Comment on Leese et al. Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals. Diabetes Care 2015;38:488-494Graham P Leese, Irene M Stratton, Martin Land, et al.
Diabetes Care|December 20, 2014
Progression of diabetes retinal status within community screening programs and potential implications for screening intervalsGraham P Leese, Irene M Stratton, Martin Land, et al.
Eye (London, England)|July 10, 2021
Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomesSobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, et al.
Eye (London, England)|March 21, 2023
Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomesSobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, et al.
Eye (London, England)|January 18, 2023
Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomesSobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, et al.
Acta Diabetologica|March 24, 2023
Serum glial fibrillary acidic protein and neurofilament light chain as biomarkers of retinal neurodysfunction in early diabetic retinopathy: results of the EUROCONDOR studyCristina Hernández, Olga Simó-Servat, Massimo Porta, et al.
Pageof 3